Ruxolitinib
Category: CancerRuxolitinib, sold under the brand names Jakafi and Jakavi, is a medication for the treatment of intermediate or high-risk myelofibrosis,[1] a type of myeloproliferative disorder that affects the bone marrow;[5][6] polycythemia vera (PCV), when there has been an inadequate response to or intolerance of hydroxyurea;[1][7] and steroid-refractory acute graft-versus-host disease.[1] It was developed and... [wikipedia]
7 DiscussionsPopular Topics
Hi, Can someone please help me? i have been on clinical trials of Ruxo for 8 weeks now... i am the 1st of my kind to be ...
23 REPLIESIs anybody out there taking the new trial drug Ruxolitinib for Mylofibrosis? ## Yes ## Hello Dave, hope all is going wel...
8 REPLIESI'm 3 yrs into Post-Essential Thrombocythemia Myelofibrosis, and I'm wondering if anyone out there has taken Rux...
3 REPLIESI hope anyone can share with me if you are currently on Ruxolitinib. I was on Ruxolitinib 40mg each day since sine Dec 2...
I am interested in how soon after starting with ruxolitinib one can feel improvement of symptoms, specifically, fever/ch...